These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
☐
|
|
Preliminary
Proxy Statement
|
|
☐
|
|
Confidential, for Use of the Commission Only (as permitted by Rule
14a-6(e)(2))
|
|
☑
|
|
Definitive
Proxy Statement
|
|
☐
|
|
Definitive
Additional Materials
|
|
☐
|
|
Soliciting
Material Pursuant to
§
240.14a-12
|
|
☑
|
|
No fee
required.
|
||
|
☐
|
|
Fee
computed on table below per Exchange Act Rules 14a-6(i)(1) and
0-11.
|
||
|
|
|
1.
|
|
Title
of each class of securities to which transaction
applies:
________________________________________
|
|
|
|
2.
|
|
Aggregate
number of securities to which transaction applies:
_______________________________________
|
|
|
|
3.
|
|
Per
unit price or other underlying value of transaction computed
pursuant to Exchange Act Rule 0-11 (Set forth the amount on which
the filing fee is calculated and state how it was
determined):
__________________
|
|
|
|
4.
|
|
Proposed
maximum aggregate value of transaction:
_______________________________________________
|
|
|
|
5.
|
|
Total
fee paid:
____________________________________________________________________________
|
|
☐
|
|
Fee
paid previously with preliminary materials.
|
||
|
☐
|
|
Check
box if any part of the fee is offset as provided by Exchange Act
Rule 0-11(a)(2) and identify the filing for which the offsetting
fee was paid previously. Identify the previous filing by
registration statement number, or the Form or Schedule and the date
of its filing.
|
||
|
|
|
1.
|
|
Amount
Previously Paid:
____________________________________________________________________
|
|
|
|
2.
|
|
Form,
Schedule or Registration Statement No:
___________________________________________________
|
|
|
|
3.
|
|
Filing
Party:
______________________________________________________________________________
|
|
|
|
4.
|
|
Date
Filed:
_______________________________________________________________________________
|
|
NOTICE
OF 2020 ANNUAL MEETING OF SHAREHOLDERS AND PROXY
STATEMENT
|
ii
|
|
IMPORTANT
NOTICE REGARDING AVAILABILITY OF PROXY MATERIALS
|
1
|
|
Record
Date and Shares Outstanding
|
1
|
|
Quorum
|
1
|
|
Important
Notice - Contingent Virtual Meeting
|
1
|
|
Shareholder
List
|
2
|
|
Attendance
at Annual Meeting
|
2
|
|
Voting
|
2
|
|
Proposals
and Required Vote for Approval
|
3
|
|
Abstentions
and Broker Non-Votes
|
3
|
|
Proxies and Revocation of Proxie
s
|
3
|
|
Solicitation
|
4
|
|
Voting
Results
|
4
|
|
Questions
|
4
|
|
PROPOSAL
NO. 1 ELECTION OF DIRECTORS
|
4
|
|
General
|
4
|
|
Vote
required
|
4
|
|
Nominees
for Director
|
4
|
|
Business
Experience and Qualifications of Nominees
|
5
|
|
Recommendation
of the Board
|
5
|
|
INFORMATION
REGARDING THE BOARD OF DIRECTORS
|
6
|
|
General
Information
|
6
|
|
Preferred
Directors
|
6
|
|
Family
Relationships
|
7
|
|
Director
Attendance at the Annual Meeting
|
7
|
|
Director
Compensation
|
7
|
|
Director
Compensation Table - Fiscal 2021
|
7
|
|
CORPORATE
GOVERNANCE
|
8
|
|
Independence
of the Board of Directors
|
8
|
|
Board
Leadership Structure
|
8
|
|
Role
of the Board in Risk Oversight
|
9
|
|
Communications
with the Board of Directors
|
9
|
|
Meetings
of the Board of Directors
|
9
|
|
Executive
Sessions
|
9
|
|
Information
Regarding Committees of the Board of Directors
|
9
|
|
Audit
Committee
|
9
|
|
Compensation
Committee
|
10
|
|
Nominating
and Governance Committee
|
10
|
|
Code
of Ethics
|
11
|
|
Prohibition
against Pledging Dynatronics Securities and Hedging
Transactions
|
11
|
|
Corporate
Governance Guidelines
|
11
|
|
Audit
Committee Report for Fiscal 2021
|
11
|
|
REPORT
OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS
|
11
|
|
PROPOSAL
NO. 2 – RATIFICATION OF SELECTION OF TANNER LLC AS THE
COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR
FISCAL 2021
|
13
|
|
General
|
13
|
|
Vote
Required
|
13
|
|
Independence
|
13
|
|
Principal
Accountant Fees and Services
|
13
|
|
Pre-approval
Policies and Procedures
|
13
|
|
Recommendation
of the Board
|
14
|
|
EXECUTIVE
COMPENSATION
|
14
|
|
Executive
Officers
|
14
|
|
Summary
Compensation Table
|
14
|
|
Our
Compensation Objectives
|
14
|
|
2021
Summary Compensation Table
|
15
|
|
Outstanding
Equity Awards at June 30, 2021
|
15
|
|
Employment
Agreements
|
16
|
|
Payments
upon Termination
|
16
|
|
Retirement
Benefits
|
16
|
|
SECURITY
OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED
STOCKHOLDERS MATTERS
|
17
|
|
Security
Ownership of Certain Beneficial Owners and
Management
|
17
|
|
Beneficial
Ownership Table
|
18
|
|
Securities
Authorized for Issuance Under Equity Compensation
Plans
|
19
|
|
Certain
Relationships and Related Transactions
|
20
|
|
SHAREHOLDER
PROPOSALS FOR 2022 ANNUAL MEETING OF
SHAREHOLDERS
|
21
|
|
Delinquent
Section 16(a) Reports
|
21
|
|
HOUSEHOLDING
OF PROXY MATERIALS
|
21
|
|
OTHER
MATTERS
|
21
|
|
John A. Krier
Director, Chief Executive Officer
Age 44
Director Since July 2020
|
Mr.
Krier has been the Chief Executive Officer since July 2020. He
joined Dynatronics in March of 2020 and served as Chief Financial
Officer until he was named the Chief Executive Officer. Prior to
joining the Company, Mr. Krier was Vice President of Marketing and
Commercial Operations at Breg, Inc., a significant Dynatronics
customer, where his work included executive leadership for
Breg’s bracing product and technology marketing teams,
including integrated applications with healthcare systems, service
solutions with third-party payer reimbursement, and customer
experience. Mr. Krier received his bachelor’s degree from the
University of South Dakota. He is a Certified Public Accountant
(inactive), and a member of the American Institute of Certified
Public Accountants and Minnesota Society of Certified Public
Accountants. We selected Mr. Krier to serve as a member of the
Board because of his many years of experience in our industry at
executive levels and the Nominating and Governance Committee
believes it is important to have our Chief Executive Officer also
serve as a member of the Board.
|
|
|
|
|
Brian D. Baker
Director, Consultant
Age 55
Director Since August 2019
|
Mr.
Baker served as our Chief Executive Officer from August 2019 to
July 2020 and as our Chief Operating Officer from May 2019 until
August 2019. Following his resignation as Chief Executive Officer,
Mr. Baker continued as an employee of the Company until October 8,
2020 and then became a consultant to the Company. From February
2018 to May 2019, Mr. Baker served as the President of our Therapy
Products Division. Prior to joining Dynatronics, he was Vice
President of Global Operations of SeaSpine Holdings Corporation
from July 2015 to January 2018, and Vice President of Operations of
the SeaSpine business within Integra LifeSciences Corporation from
March 2015 to July 2015. From November 2013 until March 2015, he
was an industry consultant providing mergers and acquisitions and
business process optimization services. He holds a B.A. degree in
business from the University of Phoenix. We selected Mr. Baker as a
member of the Board because of his extensive industry experience
and the insights gained from his work with restructuring our
operations during his service as an executive officer of the
Company.
|
|
|
|
|
Scott A. Klosterman
Director
Age 63
Director since 2016
Independent Director
|
Mr. Klosterman is Chief of Staff at
HNI Healthcare, a technology-enabled physician
management
company, since April
2020 where he previously served as Chief Financial Officer
(2018-2020) and
Executive Vice
President of Financial Operations (2016-2017). From 2010 to 2015,
he was Vice President and General Manager,
Post-Operative Products and
Services at Hanger, Inc., a leading provider of
prosthetic, orthotic, and therapeutic solutions. From 2009 to 2010,
he was an executive consultant, providing consulting services to
healthcare businesses, advising on product development and new
product launches. He was
Division President of Chattanooga Group from 2003
to 2008, where he previously served as Chief Operating Officer
(1997-2003) and Chief Financial Officer, Secretary, and Treasurer
(1994-1997). He was a licensed certified public accountant in
Pennsylvania from 1982 until 1994 and has an M.B.A. degree from
Baylor University and a B.S. degree in
Accounting (with highest honors) from the
University of Delaware. We selected
Mr. Klosterman to serve on our Board based on his extensive
experience in the medical industry and as a finance
executive.
|
|
R. Scott Ward, Ph.D.
Director
Age 65
Director since 2013
Independent Director
|
Dr.
Ward serves as the chairman of the Department of Physical Therapy
at the University of Utah. He is the past president of the American
Physical Therapy Association, a position he held from 2006 to 2012.
In addition, Dr. Ward served as chair of the rehabilitation
committee of the American Burn Association. He has published
extensive research studies related to wound care and burn
rehabilitation. Dr. Ward received a B.A. degree in Physical Therapy
and a Ph.D. degree in Physiology from the University of Utah. We
selected Dr. Ward to serve as a member of our Board based on his
prominence in his field, and his extensive experience and expertise
in physical therapy.
|
|
|
|
|
Name
(a)
|
Fees Earned or
Paid in Cash
($)
(b)
(1
)
|
Stock Awards
($)
(c)
(1)
|
All other Compensation
($)
(g)
(2)
|
Total
($)
(h)
|
|
Brian
Baker
|
$
7,500
|
$
4,350
|
$
34,280
|
$
46,130
|
|
Erin S.
Enright
|
$
12,500
|
$
21,250
|
$
-
|
$
33,750
|
|
David B.
Holtz
|
$
12,500
|
$
21,250
|
$
-
|
$
33,750
|
|
Scott A.
Klosterman
|
$
12,500
|
$
21,250
|
$
-
|
$
33,750
|
|
Brian M.
Larkin
|
$
7,500
|
$
16,250
|
$
-
|
$
23,750
|
|
R.
Scott Ward, Ph.D.
|
$
7,500
|
$
16,250
|
$
-
|
$
23,750
|
|
|
July 1, 2020
|
January 1, 2021
|
Total
|
|
Mr.
Baker
|
$
-
|
$
4,350
|
$
4,350
|
|
Ms.
Enright
|
$
16,900
|
$
4,350
|
$
21,250
|
|
Mr.
Holtz
|
$
16,900
|
$
4,350
|
$
21,250
|
|
Mr.
Larkin
|
$
11,900
|
$
4,350
|
$
16,250
|
|
Mr.
Klosterman
|
$
16,900
|
$
4,350
|
$
21,250
|
|
Dr.
Ward
|
$
11,900
|
$
4,350
|
$
16,250
|
|
Grant
Date stock price
|
$
0.88
|
$
0.87
|
|
|
Aggregate
share value
|
$
74,502
|
$
26,100
|
$
100,600
|
|
Name
|
|
Audit
|
|
Compensation
|
|
Nominating and Governance
|
|
Erin S.
Enright
|
|
X
|
|
X
|
|
*
|
|
David
B. Holtz
|
|
*
|
|
|
|
X
|
|
Scott
A. Klosterman
|
|
X
|
|
*
|
|
X
|
|
Brian
M. Larkin
|
|
|
|
X
|
|
X
|
|
R.
Scott Ward, Ph.D.
|
|
|
|
X
|
|
|
|
Brian
D. Baker
|
|
|
|
|
|
|
|
Type of Service and
Fee
|
2020
|
2021
|
|
Audit Fees
(1)
|
$
185,406
|
$
244,912
|
|
Audit Related Fees
(2)
|
$
11,700
|
$
11,650
|
|
Tax
Fees
|
|
|
|
All Other
Fees
|
|
|
|
Total
Fees
|
$
197,106
|
$
256,562
|
|
|
|
|
|
|
|
Name
|
|
Age
|
|
Position
|
|
John A.
Krier
(1)
|
|
44
|
|
President,
Chief Executive Officer, and Director
|
|
Skyler
Black
(2)
|
|
38
|
|
Corporate
Controller and Corporate Secretary
|
|
Norman
Roegner III
(3)
|
|
46
|
|
Chief
Financial Officer
|
|
|
|
|
|
|
|
Name and principal
position
(a)
|
|
Salary
($)
(c)
|
Stock awards ($) (e)
|
Option awards
($)
(f)
|
All other
compensation
($)
(i)
(1)
|
Total
|
|
Brian
D. Baker
|
2021
|
$
82,500
|
-
|
-
|
$
48,737
|
$
131,237
|
|
President and Chief Executive
Officer
(2)
|
2020
|
$
268,097
|
$
69,500
|
$
18,557
|
$
9,730
|
$
365,884
|
|
John A.
Krier
|
2021
|
$
249,179
|
$
46,370
|
$
6,498
|
$
20,872
|
$
322,919
|
|
President and Chief Executive
Officer
(3)
|
2020
|
$
57,500
|
-
|
$
17,744
|
$
5,645
|
$
80,899
|
|
Norman Roegner
III
|
2021
|
$
141,563
|
$
7,768
|
-
|
$
12,706
|
$
162,037
|
|
Chief Financial Officer
|
2020
|
-
|
-
|
-
|
-
|
-
|
|
Jennifer
Keeler
|
2021
|
$
203,627
|
-
|
-
|
$
20,689
|
$
224,316
|
|
General Counsel and Corporate
Secretary
(4)
|
2020
|
$
130,769
|
-
|
-
|
$
10,803
|
$
141,572
|
|
Skyler
Black
|
2021
|
$
158,250
|
-
|
-
|
$
16,897
|
$
175,147
|
|
Corporate Controller
|
2020
|
$
156,086
|
-
|
-
|
$
15,765
|
$
171,851
|
|
|
Option awards
|
Stock awards
|
||||
|
Name
|
Number of securities underlying
unexercised options (#) exercisable
|
Number of securities underlying
unexercised options (#) unexercis-able
|
Option exercise price ($)
|
Option expiration date
|
Number of shares or units of stock that have not vested
(#)
|
Market value of shares or units of stock that have not vested
($)
|
|
(a)
|
(b)
|
(c)
|
(e)
|
(f)
|
(g)
|
(h)
|
|
Brian
D. Baker
|
37,500
|
52,500
|
$
1.39 to $2.70
|
2/27/2026
to 8/25/2027
|
37,500
|
45,000
|
|
John
A. Krier
|
8,750
|
41,250
|
$
0.93 to $1.12
|
3/22/2027
to 7/6/2027
|
50,000
|
60,000
|
|
Norman
Roegner III
|
-
|
-
|
-
|
-
|
10,000
|
12,000
|
|
Jennifer
Keeler
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Skyler
Black
|
-
|
-
|
-
|
-
|
-
|
-
|
|
Name/Address
of Beneficial Owner
(1)
|
Title of
Class
|
No. of
Shares of each
Class
Beneficially
Owned
|
Percent of Class
Beneficially
Owned
|
Total No. of Shares Beneficially
Owned
|
Percent of Total Voting
Power
|
|
Greater than 5% Shareholders:
|
|
|
|
|
|
|
Stuart
M. Essig
(2)
|
Common
|
2,149,671
|
11.8%
|
3,289,671
|
12.1%
|
|
|
Series
A
|
880,000
|
44.2%
|
|
|
|
|
Series
B
|
260,000
|
19.1%
|
|
|
|
Stuart
M. Essig 2007 Family Trust
(3)
|
Common
|
643,500
|
3.6%
|
872,300
|
2.6%
|
|
|
Series
A
|
188,800
|
9.5%
|
|
|
|
|
Series
B
|
40,000
|
2.9%
|
|
|
|
Provco
Ventures I, LP
(4)
|
Common
|
1,599,375
|
8.8%
|
2,283,375
|
7.8%
|
|
|
Series
A
|
484,000
|
24.3%
|
|
|
|
|
Series
B
|
200,000
|
14.7%
|
|
|
|
Armistice
Capital, LLC
(5)
|
Common
|
2,760,000
|
14.7%
|
3,260,000
|
10.2%
|
|
|
Series
B
|
500,000
|
36.8%
|
|
|
|
Nancy
K. Cronin
(6)
|
Common
|
978,161
|
5.6%
|
978,161
|
4.8%
|
|
|
|
|
|
|
|
|
Directors and Named Executive Officers:
|
|
|
|
|
|
|
Brian
D. Baker (CEO/Director)
(7)
|
Common
|
171,961
|
1.0%
|
267,961
|
*
|
|
|
Series
A
|
96,000
|
4.8%
|
|
|
|
John A.
Krier (CEO/Director)
(8)
|
Common
|
47,322
|
*
|
47,322
|
*
|
|
|
|
|
|
|
|
|
Erin S. Enright (Director)
(9)
|
Common
|
643,500
|
3.6%
|
872,300
|
2.6%
|
|
|
Series A
|
188,800
|
9.5%
|
|
|
|
|
Series
B
|
40,000
|
2.9%
|
|
|
|
David
B. Holtz (Director)
(10)
|
Common
|
99,829
|
*
|
99,829
|
*
|
|
Scott
A. Klosterman (Director)
(11)
|
Common
|
99,829
|
*
|
99,829
|
*
|
|
Brian M. Larkin (Director)
(12)
|
Common
|
252,771
|
1.4%
|
320,771
|
1.2%
|
|
|
Series A
|
48,000
|
2.4%
|
|
|
|
|
Series
B
|
20,000
|
1.5%
|
|
|
|
R.
Scott Ward (Director)
(13)
|
Common
|
82,078
|
*
|
82,078
|
*
|
|
Norman
Roegner III (CFO)
(14)
|
Common
|
7,680
|
*
|
7,680
|
*
|
|
Jennifer
Keeler (General Counsel and Corporate Secretary)
(15)
|
Common
|
-
|
*
|
-
|
*
|
|
Skyler
Black (Corporate Controller and Corporate Secretary)
(16)
|
Common
|
-
|
*
|
-
|
*
|
|
|
|
|
|
|
|
|
All executive officers and directors as a group (11
persons)
|
Common
|
1,404,970
|
8.0%
|
1,979,770
|
6.2%
|
|
|
Series
A
|
332,800
|
16.7%
|
|
|
|
|
Series
B
|
60,000
|
4.4%
|
|
|
|
Plan category
|
Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights
(a)
|
Weighted-average
exercise price of
outstanding
options, warrants
and rights
(b)
|
Number of securities
remaining available for
future issuance
under
equity compensation
plans
(excluding securities
reflected in column (a))
(c)
|
|
Equity compensation plans approved by security
holders
|
|
|
|
|
2020 Plan
|
-
|
-
|
1,000,000
|
|
2018 Plan
|
140,000
|
$1.56
|
290,656
|
|
Total
|
140,000
|
|
1,290,656
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|